Ataxia telangiectasia

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Corticosteroid 1 substance
Phase III: 3

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

3 trials
  • Intrabio Limited Commercial
    L-ACETYLLEUCINE
    2024-517706-29-00 3 countries 2025 n=70 Orphan
    Recruiting
  • Quince Therapeutics S.p.A. Commercial
    DEXAMETHASONE SODIUM PHOSPHATE
    2023-509077-23-00 7 countries 2024 n=67 Orphan
    Ended
  • Quince Therapeutics S.p.A. Commercial
    DEXAMETHASONE SODIUM PHOSPHATE
    2024-513618-37-00 6 countries 2024 n=58 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Quince Therapeutics S.p.A. Commercial 2 Phase III 0
Intrabio Limited Commercial 1 Phase III 1
New trials by year
2024
2
2025
1
← All indication landscapes